Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is an aggressive thoracic cancer that is mainly associated with prior exposure to asbestos fibers. Despite being a rare cancer, its global rate is increasing and the prognosis remains extremely poor. Over the last two decades, despite the constant research of new...

Full description

Bibliographic Details
Main Authors: MHD Ouis Al Khatib, Giulia Pinton, Laura Moro, Chiara Porta
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
EZH2
malignant pleural mesothelioma
epigenetic
tumor microenvironment
macrophages
immune infiltrate
Online Access:https://www.mdpi.com/2072-6694/15/5/1537

Similar Items

Similar Items